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Abstract
Parkinson’s disease (PD) is linked to the formation of insoluble fibrillar aggregates of the presynaptic protein a-Synuclein
(aS) in neurons. The appearance of such aggregates coincides with severe motor deficits in human patients. These deficits
are often preceded by non-motor symptoms such as sleep-related problems in the patients. PD-like motor deficits can be
recapitulated in model organisms such as Drosophila melanogaster when aS is pan-neurally expressed. Interestingly, both
these deficits are more severe when aS mutants with reduced aggregation properties are expressed in flies. This indicates
that that aS aggregation is not the primary cause of the PD-like motor symptoms. Here we describe a model for PD in
Drosophila which utilizes the targeted expression of aS mutants in a subset of dopadecarboxylase expressing serotonergic
and dopaminergic (DA) neurons. Our results show that targeted expression of pre-fibrillar aS mutants not only recapitulates
PD-like motor symptoms but also the preceding non-motor symptoms such as an abnormal sleep-like behavior, altered
locomotor activity and abnormal circadian periodicity. Further, the results suggest that the observed non-motor symptoms
in flies are caused by an early impairment of neuronal functions rather than by the loss of neurons due to cell death.
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Introduction
Parkinson’s disease (PD) correlates with the formation of
insoluble fibrillar aggregates in the central nervous system that
contain a-Synuclein (aS) [1,2]. Importantly, misfolding of aS and
aggregation of the protein can be aggravated by point mutations in
the aS gene. Mutations that alter the aS fibrillation characteristics,
such as the A53T mutation [3] were found to cause an autosomal
dominant form of PD [3–5]. In addition to A53T, a number of aS
mutants with impaired ß-structure have been generated and
shown to aggregate much later than wild type aS [6]. Pan-
neuronal expression of these mutant aS proteins, which aggregate
less efficiently than wild type aS, causes PD-like motor symptoms
more efficiently than wild type aS when expressed in neurons of
model organisms such as Drosophila melanogaster (reviewed in [7])
and Caenorhabditis elegans [6]. The most effective pre-fibrillar aS
mutant tested so far consists of three alanine replacements by
prolines (at positions A30P, A56P and A76P; ‘‘TP-aS’’). TP-aSi s
strongly impaired in amyloid fibril formation and fails to aggregate
[6]. This observation suggests that soluble pre-fibrillar aS
oligomers are in fact responsible for causing motor symptoms
observed in PD and other neurodegenerative diseases, in
agreement with earlier proposals [8,9].
Interestingly, motor-impairment in PD patients is known to be
often preceded by non-motor symptoms such as sleep problems.
Therefore, we asked whether pre-fibrillar aS mutations can also
induce PD-like non-motor symptoms in Drosophila. We expressed
aS mutant protein in a subset of neurons, that includes the
serotonergic and dopaminergic (DA) neurons of Drosophila and flies
were examined for alterations in their sleep behavior and circadian
activity. Here we report that the expression of pre-fibrillar aS
mutant proteins does indeed cause non-motor symptoms in flies;
these include an altered sleep-like rest behavior [10], an extended
circadian rhythm, as well as an abnormal locomotion. Important-
ly, these symptoms were all observed prior to cell death, strongly
suggesting that it is the early impairment of the DA system, by the
pre-fibrillar aS proteins, that is responsible for the observed non-
motor symptoms. Our results present a powerful genetic model for
PD, allowing the dissection of the underlying mechanisms by
which non-aggregating aS impairs the DA system and causes non-
motor symptoms.
Results
Recent results have shown that pan-neuronal expression of pre-
fibrillar oligomers of mutant aS causes PD-like motor symptoms in
Drosophila [6]. Importantly, these mutant aS proteins show reduced
fibrillization propensity, but form increased amounts of soluble
oligomers in comparison to aggregating wild type aS [6]. One of
the aS mutants, A53T-aS, is linked to familial PD [3]. It forms
pre-fibrillar aS oligomers that aggregate later than wild type aS
[6]. A second mutant, the triple alanine to proline mutation TP-aS
forms pre-fibrillar oligomers but fails to aggregate. Upon pan-
neuronal expression, the strength of the motor symptoms and cell
toxicity correlate with the aggregation properties of the protein
(wild type aS,A53T-aS,TP-aS; details in [6]).
In order to explore whether expression of the TP-aS and A53T-
aS mutant proteins causes PD-like non-motor symptoms in flies,
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using the Ddc-Gal4 [12] and TH-Gal4 [13] drivers. They allow
UAS-dependent aS mutant transgene expression in both seroto-
nergic and dopaminergic (DA) neurons [12] and in DA neurons
[13], respectively. Positional effects can complicate analysis of
transgenes, particular when transgenes have inserted randomly
into different positions and are subject to varying positional effects.
Therefore, to precisely insert the different transgenes into the same
pre-determined chromosomal locations, we used the wC31-based
site-specific recombination system [14]. As controls for the possible
effects aS mutant, we expressed wild type aS (WT-aS) and
bacterial lacZ under otherwise identical conditions.
Expression of aS mutants affects the sleep-like rest
behavior of flies
The Ddc-Gal4-dependent expression of aS or mutant aS
proteins in flies and resulting PD-like motor symptoms have been
described (see [6,15]). However, non-motor symptoms, such as the
abnormal sleep behavior seen in PD patients [16,17], have not
been addressed in a simple animal PD model organism. Therefore,
we asked whether the sleep-like rest of flies [10], to which we refer
to as ‘‘sleep’’, is affected in flies expressing wild type aS, A53T-aS
or TP-aS.
Sleep in flies includes canonical features of mammalian sleep
[10,18–20]. We tested whether the number of sleep episodes
(‘‘bout number’’), the length of sleep episodes (‘‘bout length’’) and
the total length of sleep (‘‘total sleep’’) [21,22] is affected in flies
expressing mutant forms of aS. Flies were raised and kept under a
12 hrs light/12 hrs day cycle (L:D=12 hrs:12 hrs) (Fig. 1A–F).
Control flies expressing lacZ or wild type aS and flies expressing
A53T-aS or TP-aS were examined three days after hatching
(‘‘young flies’’).
When compared to lacZ expression, the expression of wild type
aS led to a higher number of sleep episodes during the light phase
(‘‘bout number’’; Fig. 1A), but the average length of each sleep
episode (‘‘bout length’’) was not significantly affected (P$0.05;
Fig. 1C). During the dark phases, wild type a-S expression led to a
reduction of bout number (Fig. 1B) but an increase in bout length
(Fig. 1D) when compared to control flies (lacZ expression).
Expression of A53T-aS and TP-aS led to a mild and strong
increase in both bout number and bout length, respectively, when
compared to lacZ expression during the light and dark phases
(Figure 1A–D). Taken together, the results show that while
expression of wild type aS interrupts the sleep of flies during the
day more frequently than occurs in lacZ expressing control flies. In
contrast, the expression of the two a-S mutants had an opposite
effect (TP-aS.A53T-aS), i.e. the number of sleep episodes was
reduced during the day (Fig. 1A), but the average length of the
sleep episodes was extended (Fig. 1C). During the night, both wild
type aS and the aS mutants reduced the number of sleep episodes
experienced by the flies (Fig. 1B), and the length of the sleep
episodes (Fig. 1D) was extended (aS.A53T.TP-aS). While the
expression of wild type aS and A53T-aS had no significant effect
on the total sleep of the flies, the expression of the TP-aS mutant
led to a significant reduction in the time the flies spent asleep
during a 24 h period (P,0.001; Figure 1E, F). However, the level
of activity in awake flies expressing wild type or mutant aS was not
significantly affected (P$0.05) (Fig. 1G; ‘‘activity index’’; see
Materials and Methods).
The results indicate that the sleep behavior of flies is altered in a
protein specific manner in response to aS, A53T and TP-aS
expression. In human PD patients, difficulty in sleep maintenance
(sleep fragmentation) is the earliest and most frequent sleep
disorder in such patients reported [16,17]. Other common sleep-
associated complains include excessive daytime sleepiness. How-
ever, a systematic exploration of sleep problems in human patients
has never been undertaken, and the etiology of the problems
remains unknown. Furthermore, it is also unclear whether some of
the sleep problems of PD patients are actually related to the
disease process itself or rather to side-effects from therapeutic
strategies employed [16,17]. Thus, it is not surprising that the
expression of aS and the aS mutants results in a variable pattern of
sleep abnormalities when compared to lacZ control gene
expression. However, it is important to note that the effects in
each experimental series can be crudely ordered according to the
biophysical properties of the proteins, i.e. their propensity to form
pre-fibrillar aS oligomers (A53T,TP-aS) instead of aggregates
(aS) (see Fig. 1A, C, D).
In summary, these findings establish that aS expression affects
the sleep behavior of young flies prior to the stage when motor
symptoms and neurotoxicity of the mutants can be detected [6,15]
(and our own observations). Thus, abnormal sleep in young flies is
likely to be caused by dysfunctional neurons system, resulting from
aS as well as aS mutant protein expression, and not only by their
degeneration which is observed concomitant with motor syn-
dromes in the older flies [6,15].
Expression of the aS mutants affects circadian locomotor
activity
The dopaminergic neuronal system of Drosophila is predicted to
play a role in circadian entrainment and in translating the
circadian molecular oscillations in clock cells into locomotor
activity of the organism [23,24]. We next asked whether the
circadian locomotor activity is affected by Ddc-Gal4 mediated pre-
fibrillar aS expression and whether the flies can anticipate the
dark-light (D:L) transition after a D:L cycle entrainment
(12 hrs:12 hrs; Fig. 2A) as reported for wild type flies [25]. This
anticipation behavior of the flies is reflected in a slow increase in
locomotor activity prior to the D:L transitions (arrows in Fig. 2B–
G).
Ddc-Gal4-driven expression of lacZ in young and old flies had no
detectable effect on the circadian locomotor activity profiles of the
flies (Fig. 2B–C). Ddc-Gal4-driven expression of wild type aS
(Fig. 2D,E), and in particular TP-aS expression (Fig. 2F,G), altered
the locomotor activity profiles. The anticipation behavior was
maintained in lacZ expressing young (1–3 days after eclosion) and
old (30 days after eclosion) control flies (Fig. 2B, C) as well as in
young and old flies expressing wild type aS (Fig. 2D, E). It was also
observed with young flies expressing the TP-aS mutant protein,
but old flies lost this behavioral characteristic in response to TP-aS
expression.
Furthermore, there is normally a maximum activity peak
before the L:D transition followed by a sharp decrease (asterisk in
Fig. 2 B–G), indicating that ‘‘sudden dark’’ represents a signal for
flies to abruptly stop their locomotion. In young flies, aS
expression causes a phasing out of the locomotion activities
(asterisk in Fig. 2 D) which is even more pronounced in flies
expressing TP-aS (circle in Fig. 2F). This effect is further
enhanced in old flies that express the mutant protein (asterisk in
Fig. 2 G), a phenomenon that is not observed with wild type aS
expressing flies. One possible explanation for this unexpected
recovery in aS expressing but not in TP-aS expressing flies is that
soluble, pre-fibrillar aS impairs neuron function, whereas aS
aggregates which form in aS, but not in TP-aS expressing cells
[6], have no such effect. In fact, 30 days after fly eclosion, the
majority of aS expressing neurons contain such aggregates, but
no massive cell death can be detected [15]. In contrast, the high
toxicity of the TP-aS mutant causes massive amounts of cell
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PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e24701Figure 1. Sleep behavior of flies expressing lacZ, wild type aS and aS mutants from Ddc-Gal4-driven UAS transgenes. Expression of
pre-fibrillar aS mutants (A53T-aS, TP-aS; see text) in young flies (3 days after hatching) affect the average number of sleep episodes (‘‘bout number’’;
A, B), the average length of sleep episodes (‘‘bout length’’; C, D), and the total length of sleep (‘‘total sleep’’; E, F) more severely than aS expression
both during the light (‘‘day’’; A, C) and dark (‘‘night’’; B, D) periods. The activity level during the wake periods (‘‘activity index’’; G) were not
significantly affected. Bars represent mean values of at least three independent experiments 6 the standard error of the mean from 32 animals that
were individually recorded in each experiment. Differences among means were determined by one-way ANOVA followed by the Newman-Keuls
Multiple Comparison post hoc test using wild type aS (Wt-aS) as control for the mutants; no asterisk: P$0.05; one asterisk: P,0.01; two asterisks:
P,0.001. lacZ and Wt-aS refer to lacZ and wild type aS control expression; A53T-aS and TP-aS to the aS mutants; for details see text.
doi:10.1371/journal.pone.0024701.g001
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aS oligomers impairs neuronal function even in young flies, with
severe age-related phenotypes perhaps reflecting the high levels of
accompanying cell death. In contrast, alive cells containing
wildtype aS aggregates retain a higher level of functionality for
longer periods due to lower neurotoxicity of aS.
In order to assess a possible effect of TP-aS expression on the
circadian rhythms of the flies, we monitored the circadian
locomotor activities under constant dark conditions (DD) with
young and old flies, respectively. Flies were raised and kept for
three days in a L:D cycle of 12 hrs light and12 hrs dark. Flies were
then transferred to continuous dark conditions (young flies) or kept
Figure 2. Locomotor activity and anticipation of the dark-light transition of flies expressing lacZ, wild type aS and the oligomer-
forming TP-aS mutant. (A) Dark-light (D:L=12 hrs:12 hrs) transition bar. (B–G) Locomotor activity profile of young flies (3 days after hatching; B,
D, F) and old flies (30 days after hatching; C, E, G); expressing lacZ (blue line; B, C), WT-aS (green line; D, E) and TP-aS (red line; F, G). Black arrows
point to the beginning of locomotor activity prior to the onset of light (anticipatory behavior of the flies). Note that old flies expressing TP-aS fail to
anticipate the onset of the light period (red arrow in F). Red asterisks show the phasing out of the maximum locomotor activities after the light-dark
switch. For details see text.
doi:10.1371/journal.pone.0024701.g002
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continuous dark (old flies). Actograms for both sets of flies were
obtained over a a period of ten days (Fig. 3A–D). Fig. 3A and B
show that the normal circadian activity of young flies is not altered
in response to either aS or TP-aS expression, i.e. they maintain
their normal periodicity (T=23.8 hrs) over a period of 10 days.
Old flies expressing aS also maintain a normal periodicity
(T=23.7 hrs), whereas old flies expressing TP-aS shift their
periodicity (T=26.7 hrs) similar to flies which lack key compo-
nents of the circadian clock control such as period [26]. These
findings establish that TP-aS expression in neurons interferes with
the circadian rhythm of aging flies.
DA neuron inactivation causes a TP-aS-like locomotor
activity phenotype
The DA system plays an as yet undefined role in regulating the
circadian locomotor activity of flies [23,24]. We sought to test
whether the circadian defects observed after TP-aS expression
relate to the DA system, and if so, whether they are due to
neuronal dysfunctions or neural degeneration. To accomplish this,
we reduced the activity in DA neurons either by expressing a
mutant Shaker potassium channel (EKO/Kir 2.1) or a bacterial
sodium channel (NaChBac) from UAS-cDNA transgenes driven
by the DA-specific TH-Gal4 driver [12]. Both ion channels
attenuate synaptic transmission from DA neurons by interfering
with their membrane excitability, but the DA neurons remain
viable instead of undergoing cell death [27,28] as has been
observed with DA neurons after expressing wild type aS protein or
aS mutants [6,15] (and our own observations). Figs. 3E, F show
that the expression of EKO/Kir 2.1 and NaChBac in DA neurons
caused a phase shift in circadian locomotor activity and gradually
extended the circadian periodicity, as also observed in response to
TP-aS expression (Fig. 3E, F). These observations suggest that the
circadian effects observed with EKO/Kir 2.1 and NaChBac
expressing flies are due to dysfunctional DA neurons rather than
the result of their elimination by cell death.
Discussion
Our results provide evidence that the expression of pre-fibrillar
aS oligomers causes non-motor symptoms in Drosophila. We made
use of an experimentally designed aS mutant protein, the TP-aS
protein, which fails to aggregate both in vitro and in vivo [6]. This
protein contains features similar to the A53T-aS mutant protein
that is linked to familial PD [3], but is more neurotoxic and causes
more severe PD-like motor symptoms when expressed in model
organisms [6]. TP-aS expression also produces more severe non-
motor symptoms in flies. It interferes with the sleep-like rest
behavior of flies (Fig. 1), their anticipation of the dark/light
transition (Fig. 2) and with the circadian periodicity (Fig. 3). These
symptoms precede the onset of motor symptoms in flies and can be
related to the impaired ß-structure of the TP-aS protein which
prevents protein aggregation (see also [6]).
Sleep abnormalities in PD patients [29,30] can be diagnosed
years before motor syndromes appear [20,31–33]. Expression of
mutant aS in DA neurons also causes sleep abnormalities in young
flies, both prior to the appearance motor deficits and before
eventual neuronal cell death [6,15]. This finding suggests that the
abnormal rest behavior of flies, a sleep-like state with character-
istics of mammalian sleep [10,18–20], is actually caused by the
dysfunction of neurons rather than their degeneration; although
degeneration does gradually increase in aging flies [6,15]. Further,
it provides support for the proposal that PD symptoms are already
initiated by pre-fibrillar oligomer formation of aS prior to its
eventual aggregation. The observation that flies expressing TP-aS
lose the capability to anticipate the onset of light (see Fig. 2G)
confirms also a link between abnormal sleep behavior and
memory deficits that have been described earlier [34]. It also
suggests that DA neurons in flies, like the DA neurons in
mammals, have a role in the modulation of the sleep-wake
transition [35,36].
In addition to sleep, TP-aS expression in DA neurons also
affects circadian periodicity and locomotor activity in an age-
dependent manner. Unfortunately, these non-motor effects are
only observed in aged flies (see Fig. 3) at a stage when neuron
degeneration is already apparent [6,15]. Thus, it remaines unclear
whether these effects are due to dysfunctional DA neurons, or their
actual cell death. However, we anticipate that these disorders
result initially from synapse dysfunction; attenuating synaptic
transmission, either by expression of EKO/Kir 2.1 or NaChBac
[27,28] produces symptoms similar to those observed after TP-aS
expression. Our results also support the recently proposed role of
the DA system in regulating circadian locomotor activity [23,24].
However, our results cannot exclude the possibility that the
neurotoxic activities of aS [6,15] and the aS mutants [6] may
actually underlie the increasingly severe phenotypes seen in aging
flies.
TP-aS expression in DA neurons interferes with the circadian
rhythm of aging flies, thus showing an intriguing similarity to
symptoms reported for patients suffering from severe PD (e.g.
[37]). In addition, TP-aS expression, and to a lesser extent
expression of the human A53T-aS mutation, affects the sleep
behavior of flies. These similarities suggest that aS-dependent non-
motor symptoms of PD are recapitulated in flies. Moreover, the
circadian clock and DA neuronal signaling mechanisms that
regulate arousal and sleep/wake cycles are conserved between
mammals and Drosophila [38]. Thus, Drosophila can be used as a
valid model for PD. Importantly, it will be possible to answer
questions that cannot be addressed in humans; the fact that
different aS mutants can be expressed from the same chromo-
somal site may help to examine the mechanisms and even
quantitative aspects of symptom-causing aS mutants in order to
not only elucidate the cause of PD-like motor symptoms but also
how they relate to the preceding non-motor symptoms.
Materials and Methods
Generation of aS mutations, transgenic flies and fly stock
keeping
aS, lacZ and aS mutant transgenes (A53T-aS, TP-aS) were
generated as described [6] using the Gal4-responsive pUAST
expression vector containing the attachment site B (attB) [14].
Transgene DNA was injected into fly embryos which were double
homozygous for both an attachment site P site (attP) and the germ-
line-specific wC31 integrase. Site-specific integration of transgenes
was verified by PCR using the set of primer pairs described [6].
For targeted transgene expression, we used the UAS/Gal4
system [11] with Ddc-Gal4 [12] and TH-Gal4 driver lines [13] as
previously described [39]. Flies were routinely kept at 25uCo n
standard fly food [40] using a 12 hs dark/12 hs light (D:L) cycle
unless otherwise stated in the Results.
Sleep and circadian behavior assays
Flies were housed under a D:L (12 hrs:12 hrs) cycle at 25uC
with equal population densities. Locomotor activity was recorded
from single males using the Drosophila Activity Monitoring (DAM)
system (Trikinetics, Waltham, USA) as described [21,22]. Briefly,
the DAM contains 32 channels, each connected to a single small
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PLoS ONE | www.plosone.org 5 September 2011 | Volume 6 | Issue 9 | e24701Figure 3. Age-dependent circadian defects in response to wild type aS, TP-aS, EKO/Kir2.1 and NaChBac expression in DA neurons.
(A, B) Double-plotted actograms of young flies (3 days after hatching) expressing wild type aS (WT-aS) (A) and TP-aS (B) under the control of the DA
neuron specific TH-Gal4 driver. T refers to circadian periodicity which is 23.8 hrs in both cases. (C, D) Double-plotted actograms of old flies (30 days
after hatching) expressing WT-aS and TP-aS. Note the different circadian periodicity in response to WT-aS (T=23.7 hrs) and TP-aS expression
(T=26.7 hrs). (E, F) Double-plotted actogram of old flies expressing EKO/Kir2.1 (E) or NaChBac (F) under the control of the DA neuron specific TH-Gal4
driver. Note the similar extension of the circadian periodicities (T=27.6 hrs and T=27.0 hrs, respectively) as observed after TP-aS expression. All
experiments (n=32–58 flies) were carried out under constant dark conditions after the animals were kept in a dark-light cycle of 12:12 hrs. T was
calculated by the Chi-squared periodogram analysis (see Materials and Methods).
doi:10.1371/journal.pone.0024701.g003
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monitored, as they ‘‘break’’ an infrared beam that bisects the
tube by moving back and forth along the container. Movements
were recorded in 1 min bins. Sleep is defined as a bout of 5 or
more minutes of inactivity [18]. The average length of a sleeping
bout was calculated as the total amount of sleep (in min.) divided
by the number of sleep periods. Thectivity index refers to the total
number of recorded movements in the DAM system divided by
the total time (in min.) that flies were awake.
To assess circadian locomotor activity, single males were
individually recorded (32 per experiment) using the DAM system.
Three independent experiments were performed for each
genotype. Animals were kept in D:L conditions (12 hrs:12 hrs),
before they were shifted to a dark only environment. Data were
analyzed with Clock Lab algorithms to extract the circadian
behavior (Actimetrics, Wilmette, USA). Double-plotted actograms,
Chi-squared or Lomb-Scragle periodograms were plotted using
MATLAB 7.4 (R 2007a) software using the Clock Lab programs
(Actimetrics, Wilmette, USA).
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